Literature DB >> 28338185

A structured blood conservation program in pediatric cardiac surgery.

A B Budak1, K McCusker, S Gunaydin.   

Abstract

OBJECTIVE: The limitation of alternative transfusion practices in infants increases the benefits of blood conservation. We analyzed the efficacy of a structured program to reduce transfusions and transfusion-associated complications in cardiac surgery PATIENTS AND METHODS: Our pediatric surgery database was reviewed retrospectively, comparing outcomes from two different time periods, after the implementation of an effective blood conservation program beginning in March 2014. A total of 214 infants (8.1±3.4 months) who underwent biventricular repair utilizing CPB (Group 1 - Blood conservation) were studied in a 12-month period (March 2014-February 2015) after the implementation of the new program, and compared with 250 infants (7.91±3.2 months) (Group 2 - Control-No blood conservation) of the previous 12-month period (March 2013-February 2014).
RESULTS: The proportion of patients transfused with red blood cells was 75.2% (N=188) in control group and reduced by 16.4% in the study group (58.8% - 126 patients, p <0.01). The mean number of transfusions was 1.25 ± 0.5 units per patient in control group and decreased to 0.7 ± 0.5 units per patient after the start of the program (p = 0.035). Cerebral oximetry demonstrated better follow-up during the operative period confirming less hemodilution in Group 1. Respiratory support, inotropic need and ICU stay were significantly better in the study group.
CONCLUSIONS: These findings, in addition to attendant risks and side effects of blood transfusion and the rising cost of safer blood products, justify blood conservation in pediatric cardiac operations. Circuit miniaturization, ultrafiltration, and reduced postoperative bleeding, presumably secondary to higher fibrinogen and other coagulation factor levels, contributed to this outcome.

Entities:  

Mesh:

Year:  2017        PMID: 28338185

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  3 in total

Review 1.  Building a patient blood management program in a large-volume tertiary hospital setting: Problems and solutions.

Authors:  Serdar Günaydın; Donat R Spahn; Kanat Özışık; Aslı Demir; Göktan Aşkın; Doğan Emre Sert; Hale Bozkurt; Ali Şampiyon; Dilek Kazancı; Arnel Boke Kılıçlı; Şeref Alp Küçüker; Ümit Kervan; Mehmet Ali Özatik
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2020-07-28       Impact factor: 0.332

2.  Recommendations on RBC Transfusion in Infants and Children With Acquired and Congenital Heart Disease From the Pediatric Critical Care Transfusion and Anemia Expertise Initiative.

Authors:  Jill M Cholette; Ariane Willems; Stacey L Valentine; Scot T Bateman; Steven M Schwartz
Journal:  Pediatr Crit Care Med       Date:  2018-09       Impact factor: 3.624

3.  Lund exhaust on hemodynamic parameters and inflammatory mediators in patients undergoing cardiac valve replacement under cardiopulmonary bypass.

Authors:  Jihong Zhu; Weimin Zhang; Guoying Shen; Xin Yu; Jige Guo; Taidi Zhong
Journal:  Exp Ther Med       Date:  2018-06-26       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.